How have IBB shares performed this year?

iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB shares have increased by 8.9% and is now trading at $147.98. View the best growth stocks for 2024 here .

When did iShares Biotechnology ETF's stock split?

iShares Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Who are iShares Biotechnology ETF's major shareholders?

Top institutional shareholders of iShares Biotechnology ETF include Farallon Capital Management LLC, Susquehanna International Group LLP, LPL Financial LLC (1.14%) and Main Management ETF Advisors LLC (1.08%).

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA) , Walt Disney (DIS) , Netflix (NFLX) , Alibaba Group (BABA) , Tesla (TSLA) , Cisco Systems (CSCO) and Micron Technology (MU) .

NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$147.98

-1.49 (-1.00%)

(As of 09/20/2024 ET)

Compare

About iShares Biotechnology ETF (NASDAQ:IBB)

Advanced Chart

Key Stats

Today's Range: $147.41
▼
$149.36
50-Day Range: $138.19
▼
$149.47
52-Week Range: $111.83
▼
$150.57
Volume: 1.88 million shs
Average Volume: 1.52 million shs
Market Capitalization: $7.96 billion
Assets Under Management: $7.61 billion
Dividend Yield: 0.27%
Net Expense Ratio: 0.45%
Aggregate Rating: Moderate Buy

ETF Overview

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

iShares Biotechnology ETF Expenses

Type	IBB	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.45%	0.56%	0.55%	0.49%	0.52%
Other Expenses	0.00%	0.33%	0.49%	0.41%	0.54%
Total Expense	0.45%	0.71%	0.71%	0.63%	0.71%
Fee Waiver	0.00%	-0.45%	-0.52%	-0.34%	-0.58%
Net Expense	0.45%	0.61%	0.61%	0.56%	0.59%

IBB ETF News Headlines

Biotech Breakout: Stocks for Your Watchlist

The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150.

September 12, 2024 | marketbeat.com

iShares Biotechnology ETF (NASDAQ:IBB) Reaches New 52-Week High at $150.24

September 21 at 5:45 AM | americanbankingnews.com

The death of Nvidia?

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

September 22, 2024 | Porter & Company (Ad)

Traders Purchase High Volume of Put Options on iShares Biotechnology ETF (NASDAQ:IBB)

September 12, 2024 | americanbankingnews.com

3 ETFs for Growth Investors to Buy and Hold for Decades

August 25, 2024 | fool.com

iShares Nasdaq Biotechnology ETF (IBB)

August 24, 2024 | uk.finance.yahoo.com

See More Headlines

IBB ETF - Frequently Asked Questions

: iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB shares have increased by 8.9% and is now trading at $147.98.
View the best growth stocks for 2024 here.
: iShares Biotechnology ETF shares split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.
: Top institutional shareholders of iShares Biotechnology ETF include Farallon Capital Management LLC, Susquehanna International Group LLP, LPL Financial LLC (1.14%) and Main Management ETF Advisors LLC (1.08%).
: Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
: Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO) and Micron Technology (MU).